05sfj0r4qkrpc3
Loading viewer...
report
Format: PDF report
Race Oncology's August 2023 strategic update outlines its clinical focus on bisantrene for cancer treatment, emphasizing optimized resource use and partnership potential.
Loading viewer...
report
Format: PDF report
Race Oncology's August 2023 strategic update outlines its clinical focus on bisantrene for cancer treatment, emphasizing optimized resource use and partnership potential.
investor_presentation
35 Pages
report
Dell Technologies
report
Bio-Rad Laboratories
report
Allakos
report
PBR
